Figure 4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

Figure 4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

<p>Internal validation of the b.TRPC model and comparison with ctDNA%. <b>A</b> and <b>B,</b> ROC curves comparing the predictive performance of b.TRPC and ctDNA% for 0.5-, 1-, and 2-year CRPC-free survival. <b>C</b> and <b>D,</b> Calibration plo...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Ruiliang Wang (17333340) (author)
Άλλοι συγγραφείς: Jing Xu (22749676) (author), Chenyi Zhu (22749679) (author), Wujianhong Liu (22749682) (author), Chengqi Jin (22749685) (author), Wentao Luo (22749688) (author), Tingting Zhao (17333385) (author), Changcheng Guo (17333361) (author), Wei Chen (22749691) (author), Bin Yang (17333400) (author)
Έκδοση: 2025
Θέματα:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Circulating tumor cells/DNA/exosomes
Genitourinary Cancers
Liquid Biopsy
Prostate Cancer
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια